Atlanta, GA, Sept. 27, 2022 (GLOBE NEWSWIRE) -- BioCircuit Technologies ®, a medical device company focused on peripheral nerve repair and neuromodulation, announces the close of a $9 million round of ...
Atlanta, GA, Oct. 19, 2023 (GLOBE NEWSWIRE) -- BioCircuit Technologies, an Atlanta-based medical device company, has received from the National Institutes of Health (NIH) a $1.9 million grant with the ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min BioCircuit is an early-stage ...
The MarketWatch News Department was not involved in the creation of this content. Funding will extend the Nerve Tape product line and accelerate clinical adoption. ATLANTA, Nov. 20, 2024 ...
When a peripheral nerve is injured or severed and requires surgery to repair, the standard treatment involves manual suturing of the nerve’s outer connective tissue, a somewhat complex process that ...
BioCircuit Technologies, which was spun off from technology licensed through Virginia Commonwealth University, has raised $9 million in debt financing and plans to bring a health care technology ...
BioCircuit Technologies, a National Institutes of Health (NIH)-funded medical device company focused on tissue repair and neural interfacing, and Smithfield BioScience, a unit of Smithfield Foods ...
Biocircuit Technologies Inc. has joined forces with Smithfield Bioscience Inc. to scale up a medical alternative to sutures for repairing nerves on the peripheral side of the body damaged in an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results